|
|
Emulsifier-free finely disperse systems of the oil-in-water and water-in-oil type
The invention claimed is: 1. Pickering emulsions, which are finely disperse water-in-oil or oil-in-water systems, comprising (1) an oil phase, (2) an aqueous phase, (3) ...
|
|
|
Isolates of pythium species which are antagonistic to Pythium ultimum
What is claimed is: 1. A biologically pure culture of Pythium isolate N2 having the identifying characteristics of ATCC 20692. 2. A biologically pure culture of Pythium ...
|
|
|
Bacterial substance and pharmaceutical composition thereof
AND PREFERRED EMBODIMENT The term "treatment" used herein is intended to cover all the controls of diseases including prevention, sustention (i.e. prevention of ...
|
|
|
Compounds, compositions, and methods for controlling biofilms
This invention relates to compounds, compositions, and methods for controlling biofilms. "Controlling" a biofilm means disrupting a biofilm and/or preventing biofilm ...
|
|
|
Cosmetic make-up composition containing a fullerene or mixture of fullerenes as a pigmenting agent
I claim: 1. A cosmetic composition in the form of an oil-in-water or water-in-oil emulsion containing an effective amount of fullerene or mixture of fullerenes as a ...
|
|
|
Benzylidenenorcamphor derivatives
What is claimed is: 1. A method for screening the skin or hair from the sun comprising applying to the skin or hair a benzylidenenorcamphor compound of the formula I ##ST...
|
|
|
Cosmetic compositions comprising a film-forming polymer a citric acid ester and a plasticizing agent
We claim: 1. A cosmetic composition for forming a film on skin, eyelashes, eyebrows, hair, or nails comprising: (a) at least one film-forming polymer; (b) at least one ...
|
|
|
Triazine derivatives
What is claimed is: 1. A cosmetic preparation, comprising at least one triazine compound of the formula ##STR60## in which R is halogen; straight-chain or branched C.sub....
|
|
|
Chlorite in the treatment of neurodegenerative disease
The invention features methods of treating a macrophage-associated neurodegenerative disease such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), or ...
|
|
|
Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
OF THE INVENTION According to the present invention, it has now been found that important advantages and improvements over prior products containing ...
|